Once-Daily Oral Dose of BeneFlax to Healthy Older Adults
NCT01846117 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2018-06-14
Summary
The investigators are investigating whether the flax lignan, secoisolariciresinol diglucoside, decreases oxidative stress and inflammation. The flax seed lignan is believed to be broken down in the body to produce the health benefits of flax. Flax lignan is separated from the whole flax seed as this compound is believed to have health effects. Decreasing oxidative stress and inflammation should improve a number of the problems associated with aging. This intervention consists of 600 milligrams of the flax lignan SDG daily or an equivalent amount of whey protein.
The investigators are comparing lignan to a placebo (whey powder) to examine whether a dietary intervention (i.e. flax seed containing lignan) might decrease oxidative stress and inflammation.
Conditions
- Oxidative Stress
- Inflammation
- Aging
- Pain
Interventions
- DIETARY_SUPPLEMENT
-
secoisolariciresinol diglucoside, vitamin D
SDG supplementation as a packet of 1.6g/day of BeneFlax containing 600 mg SDG for 24 weeks Vitamin D Natural Product Number (NPN) 80003663 WN Pharmaceuticals Natural Factors Whey Factors
Sponsors & Collaborators
-
Saskatchewan Health Research Foundation
collaborator OTHER -
University of Saskatchewan
lead OTHER
Principal Investigators
-
Jennifer Jones, MD, FRCPC · University of Saskatchewan
-
Jane Alcorn, DVD, PhD · University of Saskatchewan
-
Susan Whiting, PhD · University of Saskatchewan
-
Kerry Mansell, BSP, PharmD · University of Saskatchewan
-
Sharyle Fowler, MD · University of Saskatchewan
-
Lilian Thorpe, MD, PhD · University of Saskatchewan
-
Thomas Hadjistavropoulos, PhD, RD · University of Regina
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- Canada
Study Locations
More Related Trials
-
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
NCT00010829 ·Status: COMPLETED ·Phase: PHASE2
-
Flaxseed Oil and Pomegranate Extract on Inflammation, Lipid Profile and Nutritional Status of Hemodialysis Patients
NCT05564676 ·Status: COMPLETED ·Phase: NA
-
Impact of Flaxseed on the Syndrome Metabolic Inflammation
NCT02132728 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Post-Menopausal Women Receiving Flaxseed
NCT01698294 ·Status: COMPLETED ·Phase: NA
-
Flaxseed for the Treatment of Hot Flashes
NCT00275704 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease
NCT00781950 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Flaxseed on Lipid Uptake and Appetite
NCT00465036 ·Status: COMPLETED ·Phase: NA
-
Flax Muffins and Cholesterol Lowering
NCT01821131 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Rapeseed and Sunflower Oils on Proteomic Biomarkers of Diseases.
NCT04867629 ·Status: COMPLETED ·Phase: NA
-
Effects of Flaxseed Supplementation in Metabolic Syndrome
NCT02497352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors
NCT00927199 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Intake of Alpha-linolenic Acid in Elderly
NCT03025620 ·Status: COMPLETED ·Phase: NA
-
Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?
NCT04632407 ·Status: UNKNOWN ·Phase: NA
-
The Effect of a Healthy Diet Containing Flaxseed and Olive Oil on Cardiovascular Disease Risk Markers
NCT04767230 ·Status: COMPLETED ·Phase: NA
-
Effect of Flax in Yogurt on Blood Cyanide Levels
NCT06491095 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Role of Gut Microbiome on Cardiovascular Health Benefits of Dietary Lignans (CardioFlax Study).
NCT04179136 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Study the Effects of Dietary Flax Beverage on Memory and Cognition
NCT04645927 ·Status: COMPLETED ·Phase: NA
-
The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
NCT02395900 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Supplementation With Linseed Oil on Blood Lipids in Vegetarians
NCT01788917 ·Status: COMPLETED ·Phase: NA
-
Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Some Indicators Related to Atherosclerosis
NCT03392025 ·Status: COMPLETED ·Phase: NA
-
Effects of Canola Oil on Blood Vessel Function in Peripheral Arterial Disease
NCT01250275 ·Status: COMPLETED ·Phase: NA
-
Flaxseed Intervention on Metabolic Syndrome
NCT00733772 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antioxidative Effect of Plantago Asiatica L. Extract
NCT01278589 ·Status: COMPLETED ·Phase: NA
-
Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer
NCT00049309 ·Status: COMPLETED ·Phase: PHASE2
-
Flaxseed in Controlling Blood Pressure of Patients
NCT04759508 ·Status: UNKNOWN ·Phase: NA